UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): December 29, 2005

 

QUIDEL CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

 

0-10961

 

94-2573850

 

(State or Other Jurisdiction
of Incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

 

 

 

 

 

 

10165 McKellar Court

 

 

 

San Diego, California

 

92121

 

(Address of Principal Executive Offices)

 

(Zip Code)

 

 

Registrant’s telephone number, including area code:            (858) 552-1100

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 7.01               Regulation FD Disclosure.

 

On December 29, 2005, Quidel Corporation (the “Company”) issued a press release announcing its receipt of FDA clearance for new claims for its QuickVue® Influenza A+B test and projecting a strong finish for the Company’s fiscal year ending December 31, 2005.  A copy of the Company’s press release is attached as Exhibit 99.1 hereto.

 

The information in this current report on Form 8-K, including the exhibit attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section.  The information in this current report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.

 

Item 9.01               Financial Statements and Exhibits.

 

(d)           Exhibits.

 

The following exhibit is furnished with this current report on Form 8-K:

 

Exhibit Number

 

Description of Exhibit

 

 

 

99.1

 

Press release, dated December 29, 2005.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: December 29, 2005

 

QUIDEL CORPORATION

 

 

 

 

 

By:

/s/ Paul E. Landers

 

 

Name:

Paul E. Landers

 

 

Its:

Senior Vice President, Chief Financial
Officer and Secretary

 

3



 

EXHIBIT INDEX

 

Exhibit Number

 

Description of Exhibit

 

 

 

99.1

 

Press release, dated December 29, 2005.

 

4